Literature DB >> 8352262

Ranitidine-associated interstitial nephritis and Fanconi syndrome.

K Neelakantappa1, G R Gallo, J Lowenstein.   

Abstract

Ranitidine is an H2 blocking agent widely used in the treatment of peptic ulcer disease. Although acute interstitial nephritis has been described in association with a related drug, cimetidine, this complication secondary to ranitidine has been reported only once before. We describe a patient who presented with acute renal failure and features of Fanconi syndrome in association with the use of ranitidine. Renal biopsy showed acute interstitial nephritis. The patient had renal tubular acidosis with alkaline urine, aminoaciduria, renal glycosuria, uricosuria, and phosphaturia. There was a marked disparity between the degree of elevation of urea nitrogen and creatinine concentrations in the serum that was attributable to diminished urea generation, since simultaneous measurement of inulin, creatinine, and urea clearances showed that they were comparably reduced. Urinary nitrogen loss in the form of aminoaciduria contributed significantly to decreased urea generation. Both acute renal failure and Fanconi syndrome resolved after treatment with prednisone.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8352262     DOI: 10.1016/s0272-6386(12)70327-x

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  7 in total

Review 1.  Pharmacologically-induced metabolic acidosis: a review.

Authors:  George Liamis; Haralampos J Milionis; Moses Elisaf
Journal:  Drug Saf       Date:  2010-05-01       Impact factor: 5.606

Review 2.  Nephrotoxicity and hepatotoxicity of histamine H2 receptor antagonists.

Authors:  A A Fisher; D G Le Couteur
Journal:  Drug Saf       Date:  2001-01       Impact factor: 5.606

3.  Granulomatous tubulointerstitial nephritis secondary to omeprazole.

Authors:  Quaid Nadri; Mohammed Mahdi Althaf
Journal:  BMJ Case Rep       Date:  2014-10-16

4.  Kidney biopsy for renal tubular acidosis: when tissue diagnosis makes a difference.

Authors:  Youshay Humayun; Patrick Sanchez; Lindsey T Norris; Divya Monga; Jack Lewin; Tibor Fülöp
Journal:  Clin Nephrol Case Stud       Date:  2015-05-22

5.  Hypokalemic Paralysis Secondary to Immune Checkpoint Inhibitor Therapy.

Authors:  Pragathi Balakrishna; Augusto Villegas
Journal:  Case Rep Oncol Med       Date:  2017-11-08

6.  Rifampin-associated tubulointersititial nephritis and Fanconi syndrome presenting as hypokalemic paralysis.

Authors:  Hong Ki Min; Eun Oh Kim; Sang Ju Lee; Yoon Kyung Chang; Kwang Sun Suh; Chul Woo Yang; Suk Young Kim; Hyeon Seok Hwang
Journal:  BMC Nephrol       Date:  2013-01-16       Impact factor: 2.388

7.  Non-diabetic glycosuria as a diagnostic clue for acute tubulointerstitial nephritis in patients with azotemia.

Authors:  Taeyeon Lee; Won Seok Yang
Journal:  Ren Fail       Date:  2020-11       Impact factor: 2.606

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.